Viome Acquires Sōlaria Biō to Expand Into Clinically Validated Synbiotics and Medical Foods
October 9, 2026
Viome acquired Sōlaria Biō, a clinically validated synbiotics and medical foods company, to expand its personalized health platform into condition-specific interventions. The deal brings Sōlaria’s microbial discovery platform, biobank, machine-learning capabilities, and products—most notably its standalone synbiotic medical food Bōndia—into Viome’s portfolio.
- Buyers
- Viome
- Targets
- Sōlaria Biō
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Solabia Acquires Mibelle Biochemistry, Seqens' Botanical Actives and IVD Activity, and Xebios Group
March 5, 2026
Biotechnology
Solabia, a Paris-headquartered biotech platform focused on natural active ingredients and diagnostics solutions, has agreed to acquire three complementary businesses as part of its international expansion strategy. The acquisitions include Switzerland-based Mibelle Biochemistry, France-based Seqens' Botanical Actives and In-Vitro Diagnostics activity, and Germany/Netherlands-based Xebios Group.
-
Sustainable Agro Solutions Acquires Ceres Biotics
January 30, 2026
Agriculture
Sustainable Agro Solutions (SAS Group), a portfolio company of Stirling Square Capital Partners, has acquired Spain-based Ceres Biotics to expand its microbial biosolutions product portfolio and R&D capabilities. The deal strengthens SAS Group's presence in Europe and adds more than 550 proprietary microbial strains; financial terms were not disclosed.
-
Artis BioSolutions To Acquire Syngoi Technologies
January 6, 2026
Biotechnology
Artis BioSolutions has signed a definitive agreement to acquire Syngoi Technologies, a Bilbao, Spain-based biotech developing enzymatic approaches for manufacturing synthetic DNA. The deal is intended to add fast, lower-cost synthetic DNA manufacturing to Artis’ gene-to-drug advanced-therapy platform, with Syngoi’s Bilbao GMP-ready facilities becoming part of Artis’ global footprint.
-
Astorg to Acquire Majority Stake in Solabia Group
May 7, 2025
Biotechnology
Astorg has signed a definitive agreement to acquire a majority stake in Solabia Group from TA Associates, with TA reinvesting alongside Astorg. Solabia, a Paris-headquartered biotech ingredients manufacturer with 11 production sites, 8 R&D labs and over 900 employees, will partner with Astorg to accelerate international expansion (particularly in the US and Asia), advance product innovation and pursue targeted M&A.
-
Viome Life Sciences Acquires Naring Health (including DiscernDX and Foodome)
November 2, 2023
Healthcare Services
Viome Life Sciences has acquired digital health startup Naring Health, including its subsidiaries DiscernDX and Foodome, to expand its capabilities in multi-omics, diagnostics and precision nutrition. The deal brings together microbiome analysis, proteomics and foodomics capabilities to enhance Viome's personalized nutrition and early disease detection offerings.
-
VeriSIM Life Acquires Molomics Biotech
May 11, 2022
Biotechnology
VeriSIM Life, an AI-driven virtual drug development company based in San Francisco, has acquired Molomics Biotech SL, a Barcelona-based AI-enabled drug discovery firm. The acquisition integrates Molomics' AI + Human Collective Intelligence discovery technology into VeriSIM's BIOiSIM platform to accelerate and improve success rates in drug discovery, including work on Parkinson's disease.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.